{"id":"W2103448296","doi":"10.1002/bdd.415","title":"A multiple‐dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin‐11 (oprelvekin)","year":2004,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Adverse effect; Placebo; Pharmacodynamics; Internal medicine; Pharmacology; Gastroenterology; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00126249,0.001103861,0.0008818271,0.0002944216,0.0002993697,0.00033326,0.0002967429,0.0005284696,0.001554146],"category_scores_gemma":[0.0009092656,0.0005200174,0.0007561276,0.0001869301,0.0006269992,0.0004301624,0.0002159727,0.001215358,0.0003868378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000250402,"about_ca_system_score_gemma":0.0003755397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003415265,"about_ca_topic_score_gemma":0.0004951939,"domain_scores_codex":[0.9995572,0.000223829,0.00001666675,0.00007966921,0.0000644901,0.00005812864],"domain_scores_gemma":[0.9991298,0.0002713073,0.0001837922,0.0001011765,0.00005804232,0.0002559248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.355051,0.07885494,0.02656622,0.000668921,0.001139261,0.0007690816,0.0006230886,0.001950908,0.4173941,0.0001910986,0.0008165202,0.1159749],"study_design_scores_gemma":[0.02103735,0.913953,0.04527673,0.000009084031,0.0002867034,0.0004674298,0.00007832109,0.0007953489,0.01665645,0.00007005709,0.001342495,0.00002710383],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986319,0.0003622599,0.0004992507,0.00003232968,0.00001835626,0.0001513497,0.00009926232,0.00001547253,0.0001897064],"genre_scores_gemma":[0.9975313,0.0003008445,0.0008260298,0.00008154355,0.00005296726,0.0002144284,0.0001762093,0.000008082378,0.0008086057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001554146,"threshold_uncertainty_score":0.006676733,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0371123415505996,"score_gpt":0.3730827713037148,"score_spread":0.3359704297531152,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}